Hong JY - Search Results

1

Clinical Implication of HER2 Aberration in Patients With Metastatic Cancer Using Next-Generation Sequencing: A Pan-Tumor Analysis.

Jung J, Kim ST, Ko J, Hong JY, Park JO, Ha SY, Lee J. Jung J, et al. Among authors: hong jy. JCO Precis Oncol. 2023 Jul;7:e2200537. doi: 10.1200/PO.22.00537. JCO Precis Oncol. 2023. PMID: 37499191

2

Palliative chemotherapy for non-transitional cell carcinomas of the urothelial tract.

Hong JY, Choi MK, Uhm JE, Park MJ, Lee J, Park SH, Park JO, Kim WS, Kang WK, Lee HM, Choi HY, Lim H. Hong JY, et al. Med Oncol. 2009;26(2):186-92. doi: 10.1007/s12032-008-9106-7. Epub 2008 Nov 6. Med Oncol. 2009. PMID: 18988001

3

The role of palliative chemotherapy for advanced pulmonary pleomorphic carcinoma.

Hong JY, Choi MK, Uhm JE, Park MJ, Lee J, Park YH, Ahn JS, Park K, Han JH, Ahn MJ. Hong JY, et al. Med Oncol. 2009;26(3):287-91. doi: 10.1007/s12032-008-9117-4. Epub 2008 Nov 7. Med Oncol. 2009. PMID: 18989796

4

Prognostic model to predict outcomes in nonsmall cell lung cancer patients treated with gefitinib as a salvage treatment.

Park MJ, Lee J, Hong JY, Choi MK, Yi JH, Lee SJ, Oh SJ, Ahn JS, Park K, Ahn MJ. Park MJ, et al. Among authors: hong jy. Cancer. 2009 Apr 1;115(7):1518-30. doi: 10.1002/cncr.24151. Cancer. 2009. PMID: 19177485 Free article.

5

Unique perception of clinical trials by Korean cancer patients.

Lee SJ, Park LC, Lee J, Kim S, Choi MK, Hong JY, Park S, Maeng CH, Chang W, Kim YS, Park SH, Park JO, Lim HY, Kang WK, Park YS. Lee SJ, et al. Among authors: hong jy. BMC Cancer. 2012 Dec 12;12:594. doi: 10.1186/1471-2407-12-594. BMC Cancer. 2012. PMID: 23234342 Free PMC article.

6

Effect of paclitaxel/carboplatin salvage chemotherapy in noncutaneous versus cutaneous metastatic melanoma.

Chang W, Lee SJ, Park S, Choi MK, Hong JY, Kim YS, Maeng CH, Jung HA, Kim S, Lee J. Chang W, et al. Among authors: hong jy. Melanoma Res. 2013 Apr;23(2):147-51. doi: 10.1097/CMR.0b013e32835efd8d. Melanoma Res. 2013. PMID: 23411477

7

Genetic aberrations in imatinib-resistant dermatofibrosarcoma protuberans revealed by whole genome sequencing.

Hong JY, Liu X, Mao M, Li M, Choi DI, Kang SW, Lee J, La Choi Y. Hong JY, et al. PLoS One. 2013 Jul 29;8(7):e69752. doi: 10.1371/journal.pone.0069752. Print 2013. PLoS One. 2013. PMID: 23922791 Free PMC article.

8

Effects of single nucleotide polymorphisms on treatment outcomes and toxicity in patients treated with sunitinib.

Maeng CH, Yi JH, Lee J, Hong JY, Choi MK, Jung HA, Park JO, Park SH, Park YS, Kang WK, Lim HY. Maeng CH, et al. Among authors: hong jy. Anticancer Res. 2013 Oct;33(10):4619-26. Anticancer Res. 2013. PMID: 24123039

9

Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients.

Hong JY, Nam EM, Lee J, Park JO, Lee SC, Song SY, Choi SH, Heo JS, Park SH, Lim HY, Kang WK, Park YS. Hong JY, et al. Cancer Chemother Pharmacol. 2014 Jan;73(1):125-30. doi: 10.1007/s00280-013-2328-1. Epub 2013 Oct 27. Cancer Chemother Pharmacol. 2014. PMID: 24162380 Clinical Trial.

10

Effect of simvastatin plus cetuximab/irinotecan for KRAS mutant colorectal cancer and predictive value of the RAS signature for treatment response to cetuximab.

Lee J, Hong YS, Hong JY, Han SW, Kim TW, Kang HJ, Kim TY, Kim KP, Kim SH, Do IG, Kim KM, Sohn I, Park SH, Park JO, Lim HY, Cho YB, Lee WY, Yun SH, Kim HC, Park YS, Kang WK. Lee J, et al. Among authors: hong jy, hong ys. Invest New Drugs. 2014 Jun;32(3):535-41. doi: 10.1007/s10637-014-0065-x. Epub 2014 Jan 28. Invest New Drugs. 2014. PMID: 24468885 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,285 results

Search Page